A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

NCT07335796 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: BMS-986165
DRUG: Degarelix

Sponsor

Memorial Sloan Kettering Cancer Center